A new study published in JAMA examined severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike immunoglobulin (Ig)G antibodies in a
Continue reading »Home »
Sexually dimorphic placental antibody transfer during SARS-CoV-2 infection
Sex-based differences in COVID-19 disease transmission, severity, and mortality have been reported since the early stages of the pandemic in
Continue reading »Targeting SARS-CoV-2 with Chaga mushroom – a natural antiviral compound
The novel coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 initially emerged
Continue reading »Research finds different antibody responses following COVID vaccination and natural infection
The coronavirus disease (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Infection with SARS-CoV-2 produces B cell
Continue reading »Antibody kinetics in recovered COVID-19 patients
The coronavirus disease 2019 (COVID-19) pandemic began nearly two years ago and rapidly spread across the globe, causing a worldwide
Continue reading »CoronaVac elicits lower antibody response than natural SARS-CoV-2 infection, study suggests
A recent study from Thailand, published in the journal Lancet Infectious Diseases, highlights a rather low degree of neutralization-afforded protection
Continue reading »SARS-CoV-2 vaccine efficacy is strongly correlated with antibody neutralization levels
All COVID-19 vaccines appear less effective when faced with variants such as Delta, according to a new medRxiv* study. However,
Continue reading »Long COVID has low prevalence in school-age children, UK study suggests
With the ongoing coronavirus disease 2019 (COVID-19) pandemic showing signs of a third wave, many researchers are exploring the long-term
Continue reading »